125 related articles for article (PubMed ID: 32768887)
1. Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC).
Perona M; Majdalani ME; Rodríguez C; Nievas S; Carpano M; Rossini A; Longhino JM; Cabrini R; Pisarev MA; Juvenal GJ; Dagrosa MA
Appl Radiat Isot; 2020 Oct; 164():109297. PubMed ID: 32768887
[TBL] [Abstract][Full Text] [Related]
2. Improvement of the boron neutron capture therapy (BNCT) by the previous administration of the histone deacetylase inhibitor sodium butyrate for the treatment of thyroid carcinoma.
Perona M; Rodríguez C; Carpano M; Thomasz L; Nievas S; Olivera M; Thorp S; Curotto P; Pozzi E; Kahl S; Pisarev M; Juvenal G; Dagrosa A
Radiat Environ Biophys; 2013 Aug; 52(3):363-73. PubMed ID: 23636505
[TBL] [Abstract][Full Text] [Related]
3. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
5. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
6. The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.
Takahara K; Inamoto T; Minami K; Yoshikawa Y; Takai T; Ibuki N; Hirano H; Nomi H; Kawabata S; Kiyama S; Miyatake S; Kuroiwa T; Suzuki M; Kirihata M; Azuma H
PLoS One; 2015; 10(9):e0136981. PubMed ID: 26325195
[TBL] [Abstract][Full Text] [Related]
7. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
[TBL] [Abstract][Full Text] [Related]
8. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
10. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
11. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
13. Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.
Dagrosa A; Carpano M; Perona M; Thomasz L; Nievas S; Cabrini R; Juvenal G; Pisarev M
Appl Radiat Isot; 2011 Dec; 69(12):1752-5. PubMed ID: 21570311
[TBL] [Abstract][Full Text] [Related]
14. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
[TBL] [Abstract][Full Text] [Related]
15. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
16. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy.
Watanabe T; Sanada Y; Hattori Y; Suzuki M
J Radiat Res; 2023 Jan; 64(1):91-98. PubMed ID: 36371738
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Study of
Watanabe T; Yoshikawa T; Tanaka H; Kinashi Y; Kashino G; Masunaga SI; Hayashi T; Uehara K; Ono K; Suzuki M
Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):443-453. PubMed ID: 37198368
[TBL] [Abstract][Full Text] [Related]
20. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
